Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT02547935
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2015-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-18
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-31
First Submit QC Date:
None
Study First Post Date:
2015-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-15
Results First Submit QC Date:
None
Results First Post Date:
2019-06-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-07
Last Update Post Date:
2019-08-21
Last Update Post Date Type:
ACTUAL